ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,078Medicare Part D Prescriptions Filled, Including Refills

Rank: 158 out of 783

$651K Total Retail Price of All Prescriptions

Rank: 167 out of 783

591 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

14% of this provider’s 591 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 9,619 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 586 520 1 3
LEVOTHYROXINE SODIUM 478 478 2 1
OMEPRAZOLE 363 319 3 6
LISINOPRIL 352 298 4 4
AMLODIPINE BESYLATE 345 269 5 5
FUROSEMIDE 333 288 6 7
HYDROCODONE-ACETAMINOPHEN 326 214 S3 7 2
METOPROLOL TARTRATE 288 272 8 9
METFORMIN HCL 216 183 9 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 198 174 10 33
WARFARIN SODIUM 194 189 11 10
ATENOLOL 192 144 12 17
ATORVASTATIN CALCIUM 162 148 13 11
HYDROCHLOROTHIAZIDE 140 113 14 12
PRAVASTATIN SODIUM 140 126 14 14
ALENDRONATE SODIUM 123 123 16 25
AMLODIPINE BESYLATE-BENAZEPRIL 122 122 17 83
METOPROLOL SUCCINATE 121 112 18 13
KLOR-CON 10 119 100 19 102
TRAMADOL HCL 115 113 20 20
POTASSIUM CHLORIDE 114 103 21 16
CRESTOR 111 85 22 27
LOSARTAN POTASSIUM 108 96 23 18
TAMSULOSIN HCL 101 101 24 26
ALLOPURINOL 97 91 25 31
GLIMEPIRIDE 97 97 25 34
ZOLPIDEM TARTRATE 93 55 27 23
DIGOXIN 89 82 28 61
CLOPIDOGREL 85 61 29 29
PANTOPRAZOLE SODIUM 84 84 30 30
DONEPEZIL HCL 82 82 31 24
GABAPENTIN 82 62 31 15
LOSARTAN-HYDROCHLOROTHIAZIDE 79 69 33 53
ENALAPRIL MALEATE 77 65 34 68
DIOVAN HCT 74 73 35 94
DIOVAN 73 68 36 49
SERTRALINE HCL 70 68 37 22
JANUVIA 67 57 38 73
CITALOPRAM HBR 66 55 39 19
SYNTHROID 65 65 40 47
CARVEDILOL 63 53 41 21
PLAVIX 63 50 41 51
ZETIA 59 57 43 80
ISOSORBIDE MONONITRATE ER 58 54 44 40
FINASTERIDE 57 52 45 127
NEXIUM 56 44 46 28
GLIPIZIDE 55 44 47 71
AMITRIPTYLINE HCL 52 49 R 48 77
GLYBURIDE-METFORMIN HCL 52 40 R 48 170
BENAZEPRIL HCL 51 46 50 85
PREDNISONE 50 43 51 36
METFORMIN HCL ER 50 49 51 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 13, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.